Chordate Medical Holding AB (CMH) — Cash Flow-to-Debt Ratio
Latest as of June 2025:
-1.72x
Chordate Medical Holding AB (CMH) has a Cash Flow-to-Debt Ratio of -1.72x as of June 2025, meaning its operating cash flow of Skr-7.14 Million could theoretically repay -2% of its total liabilities (Skr4.14 Million) in one year. See Chordate Medical Holding AB leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-1.72x
Operating CF / Total Liabilities
Operating Cash Flow
Skr-7.14 Million
SEK
Total Liabilities
Skr4.14 Million
SEK
Data as of
Jun 2025
Most recent filing
Chordate Medical Holding AB Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Chordate Medical Holding AB across 10 annual periods. For the full cash flow conversion analysis, see CMH cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Chordate Medical Holding AB (2015–2024)
Year-by-year debt coverage analysis for Chordate Medical Holding AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.93x | Skr-24.41 Million | Skr8.34 Million | ▲ +26.2% |
| 2023 | -3.97x | Skr-27.26 Million | Skr6.87 Million | ▼ -20.3% |
| 2022 | -3.30x | Skr-24.98 Million | Skr7.57 Million | ▲ +17.0% |
| 2021 | -3.98x | Skr-20.34 Million | Skr5.11 Million | ▼ -27.3% |
| 2020 | -3.13x | Skr-17.43 Million | Skr5.58 Million | ▼ -45.2% |
| 2019 | -2.15x | Skr-16.95 Million | Skr7.87 Million | ▼ -11.7% |
| 2018 | -1.93x | Skr-18.99 Million | Skr9.86 Million | ▼ -10.7% |
| 2017 | -1.74x | Skr-18.99 Million | Skr10.91 Million | ▼ -109.0% |
| 2016 | -0.83x | Skr-9.64 Million | Skr11.58 Million | ▲ +20.3% |
| 2015 | -1.05x | Skr-12.42 Million | Skr11.89 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.